Monday, 26 June 2017

Pelican BioThermal Unveils New Series 22 Universal System

19 May 2017 | News

The company announced new solution for controlled room temperature distribution challenges

Pelican BioThermal recently launched Series 22 Universal for its Crēdo™ shippers.

One of two temperature-controlled options for Pelican BioThermal controlled room temperature (CRT) cold chain packaging, Series 22 Universal is designed to address the challenges of managing CRT thermal requirements in pharmaceutical distribution.

Series 22 Universal uses a dual phase change material (PCM) coolant system, which is designed for operational ease of use year round, as well as high performance in any temperature conditions. This system takes advantage of two variants of PCM to maintain a CRT payload space between 15-25 degrees Celsius, offering hot and cold protection throughout the Crēdo shipper’s journey.  

Kevin Lawler, Pelican BioThermal vice president of sales said, “Our Series 22 Universal, for Crēdo shippers, offers simplicity in managing CRT shipments. It offers operational ease of use year round and high performance in any thermal conditions.”

Series 22 Universal uses 16° C and 24° C PCM for use in year round ambient conditions. Features and benefits include:

  • Simple universal conditioning and pack out regardless of hot or cold ambient conditions the Crēdo shipper is exposed to during its journey
  • Dual TIC™ design means that the two PCMs are conditioned together in one environment, eliminating the need to determine when to use summer or winter processes
  • Added protection against cold shocks and heat spikes from the external environment, due to protection offered by two complementary phase points.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls